{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:11:48Z","timestamp":1794085908015,"version":"4.8.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AA014095"],"award-info":[{"award-number":["U01 AA014095"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AA010761"],"award-info":[{"award-number":["P50 AA010761"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014552","name":"Adlerbertska Research Foundation","doi-asserted-by":"publisher","award":["2024-791"],"award-info":[{"award-number":["2024-791"]}],"id":[{"id":"10.13039\/501100014552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014552","name":"Adlerbertska Research Foundation","doi-asserted-by":"publisher","award":["2024-SA-4698"],"award-info":[{"award-number":["2024-SA-4698"]}],"id":[{"id":"10.13039\/501100014552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008550","name":"Swedish Diabetes Association Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009556","name":"Systembolaget Aktiebolag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003745","name":"Wilhelm och Martina Lundgrens Stiftelser","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014197","name":"Foundation Mary von Sydow born Wijk Donation Fund","doi-asserted-by":"publisher","award":["2024-36"],"award-info":[{"award-number":["2024-36"]}],"id":[{"id":"10.13039\/501100014197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014197","name":"Foundation Mary von Sydow born Wijk Donation Fund","doi-asserted-by":"publisher","award":["2024-185"],"award-info":[{"award-number":["2024-185"]}],"id":[{"id":"10.13039\/501100014197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2023\/18470-5"],"award-info":[{"award-number":["2023\/18470-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008546","name":"Diabetesf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008546","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005760","name":"G\u00f6teborgs Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009252","name":"Science for Life Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska University Hospital","doi-asserted-by":"publisher","award":["723941"],"award-info":[{"award-number":["723941"]}],"id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska University Hospital","doi-asserted-by":"publisher","award":["1005347"],"award-info":[{"award-number":["1005347"]}],"id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Foundation","doi-asserted-by":"publisher","award":["M24-0216"],"award-info":[{"award-number":["M24-0216"]}],"id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009535","name":"Systembolaget AB","doi-asserted-by":"publisher","award":["FO2024-0048"],"award-info":[{"award-number":["FO2024-0048"]}],"id":[{"id":"10.13039\/501100009535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2020-01463"],"award-info":[{"award-number":["2020-01463"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2023-2600"],"award-info":[{"award-number":["2023-2600"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2024-03054"],"award-info":[{"award-number":["2024-03054"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2020-00559"],"award-info":[{"award-number":["2020-00559"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007678","name":"Center for Modelling and Simulation in the Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007678","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK6BX006299"],"award-info":[{"award-number":["IK6BX006299"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ebiom.2025.106119","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T10:50:54Z","timestamp":1767783054000},"page":"106119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Tirzepatide reduces alcohol drinking and relapse-like behaviours in rodents"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1995-2025","authenticated-orcid":false,"given":"Christian E.","family":"Edvardsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Adermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2342-0900","authenticated-orcid":false,"given":"Sam","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safana","family":"Alfreji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8581-4182","authenticated-orcid":false,"given":"Thaynnam A.","family":"Emous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yomna","family":"Gouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Thorsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Vuji\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cajsa","family":"Aran\u00e4s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Benrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Wernstedt Asterholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo F.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Jerlhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ebiom.2025.106119_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106119_bib2","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41386-020-00950-y","article-title":"Addiction as a brain disease revised: why it still matters, and the need for consilience","volume":"46","author":"Heilig","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106119_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.3340","article-title":"Sobering perspectives on the treatment of alcohol use disorder","volume":"7","author":"Yaseen","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106119_bib4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1037\/amp0000059","article-title":"Liking, wanting, and the incentive-sensitization theory of addiction","volume":"71","author":"Berridge","year":"2016","journal-title":"Am Psychol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106119_bib5","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.neubiorev.2012.04.005","article-title":"Do initial responses to drugs predict future use or abuse?","volume":"36","author":"de Wit","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106119_bib6","first-page":"108","article-title":"Alcohol and dopamine","volume":"21","author":"Di Chiara","year":"1997","journal-title":"Alcohol Health Res World"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106119_bib7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1176\/appi.ajp.2020.20030247","article-title":"Subjective responses to alcohol in the development and maintenance of alcohol use disorder","volume":"178","author":"King","year":"2021","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106119_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1176\/appi.ajp.20240069","article-title":"Real-time assessment of alcohol reward, stimulation, and negative affect in individuals with and without alcohol use disorder and depressive disorders","volume":"182","author":"King","year":"2025","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106119_bib9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106119_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuron.2019.01.016","article-title":"The molecular basis of drug addiction: linking epigenetic to synaptic and circuit mechanisms","volume":"102","author":"Nestler","year":"2019","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106119_bib11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrn.2016.85","article-title":"Molecular mechanisms underlying alcohol-drinking behaviours","volume":"17","author":"Ron","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106119_bib12","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nrn2234","article-title":"Synaptic plasticity and addiction","volume":"8","author":"Kauer","year":"2007","journal-title":"Nat Rev Neurosci"},{"issue":"872","key":"10.1016\/j.ebiom.2025.106119_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adq0031","article-title":"The biology of addiction","volume":"18","author":"Nestler","year":"2025","journal-title":"Sci Signal"},{"key":"10.1016\/j.ebiom.2025.106119_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107312","article-title":"IUPHAR review - Glucagon-like peptide-1 (GLP-1) and substance use disorders: an emerging pharmacotherapeutic target","volume":"207","author":"Bruns Vi","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ebiom.2025.106119_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.11.005","article-title":"Gut-brain axis and addictive disorders: a review with focus on alcohol and drugs of abuse","volume":"196","author":"Jerlhag","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106119_bib16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/bph.15677","article-title":"The role of glucagon-like peptide 1 (GLP-1) in addictive disorders","volume":"179","author":"Klausen","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106119_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/JCI188314","article-title":"Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake","volume":"135","author":"Farokhnia","year":"2025","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106119_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2468-1253(25)00134-7","article-title":"GLP-1 receptor agonists in alcohol use disorder and alcohol-associated liver disease","volume":"10","author":"Singal","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106119_bib19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/ijo.2012.208","article-title":"Incretin hormones and the satiation signal","volume":"37","author":"Holst","year":"2013","journal-title":"Int J Obes"},{"issue":"15","key":"10.1016\/j.ebiom.2025.106119_bib20","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1016\/j.cell.2024.06.003","article-title":"Transforming obesity: the advancement of multi-receptor drugs","volume":"187","author":"Kusminski","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106119_bib21","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1037\/pha0000620","article-title":"Glucagon-like peptide-1 receptors in nucleus accumbens, ventral hippocampus, and lateral septum reduce alcohol reinforcement in mice","volume":"31","author":"Allingbjerg","year":"2023","journal-title":"Exp Clin Psychopharmacol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106119_bib22","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.psyneuen.2012.11.009","article-title":"The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents","volume":"38","author":"Egecioglu","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ebiom.2025.106119_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.psyneuen.2019.02.006","article-title":"Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents","volume":"103","author":"Vall\u00f6f","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ebiom.2025.106119_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105684","article-title":"An inhibitory GLP-1 circuit in the lateral septum modulates reward processing and alcohol intake in rodents","volume":"115","author":"Edvardsson","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2025.106119_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104642","article-title":"Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats","volume":"93","author":"Aran\u00e4s","year":"2023","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106119_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170671","article-title":"The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission","volume":"8","author":"Chuong","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2025.106119_bib27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2019.02.020","article-title":"Glucagon-like peptide-1 receptors within the nucleus of the solitary tract regulate alcohol-mediated behaviors in rodents","volume":"149","author":"Vall\u00f6f","year":"2019","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106119_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00213-024-06637-2","article-title":"Effect of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide on alcohol consumption in alcohol-preferring male vervet monkeys","volume":"242","author":"Fink-Jensen","year":"2025","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106119_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapsychiatry.2024.4789","article-title":"Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial","volume":"82","author":"Hendershot","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"19","key":"10.1016\/j.ebiom.2025.106119_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159863","article-title":"Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial","volume":"7","author":"Klausen","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106119_bib31","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1038\/s41467-024-48780-6","article-title":"Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106119_bib32","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/dom.16152","article-title":"Glucagon-like peptide-1 analogues reduce alcohol intake","volume":"27","author":"O'Farrell","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106119_bib33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106119_bib34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ebiom.2025.106119_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140532","article-title":"Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist","volume":"5","author":"Willard","year":"2020","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106119_bib36","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1038\/s41380-025-03199-3","article-title":"Genetically modeled GLP1R and GIPR agonism reduce binge drinking and alcohol-associated phenotypes: a multi-ancestry drug-target Mendelian randomization study","volume":"30","author":"Reitz","year":"2025","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106119_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s13679-024-00560-5","article-title":"Alcohol drinking impacts on adiposity and steatotic liver disease: concurrent effects on metabolic pathways and cardiovascular risks","volume":"13","author":"Mart\u00ednez-Urbistondo","year":"2024","journal-title":"Curr Obes Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106119_bib38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2022.08.030","article-title":"Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease","volume":"78","author":"\u00c5berg","year":"2023","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106119_bib39","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3748\/wjg.v16.i11.1304","article-title":"Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development","volume":"16","author":"Wang","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106119_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainresrev.2004.04.009","article-title":"Regulation of affect by the lateral septum: implications for neuropsychiatry","volume":"46","author":"Sheehan","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.ebiom.2025.106119_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/7854_2024_461","article-title":"Animal models of excessive alcohol consumption in rodents","volume":"71","author":"Becker","year":"2025","journal-title":"Curr Top Behav Neurosci"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106119_bib42","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00702-025-02928-w","article-title":"Alcohol-induced accumbal dopamine- and taurine release in female and male Wistar rats, an in vivo microdialysis study","volume":"132","author":"Loft\u00e9n","year":"2025","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.ebiom.2025.106119_bib43","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84604","article-title":"A stable, distributed code for cue value in mouse cortex during reward learning","volume":"12","author":"Ottenheimer","year":"2023","journal-title":"Elife"},{"issue":"23","key":"10.1016\/j.ebiom.2025.106119_bib44","doi-asserted-by":"crossref","first-page":"E3300","DOI":"10.1073\/pnas.1605973113","article-title":"Combinatorial effects of odorants on mouse behavior","volume":"113","author":"Saraiva","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.106119_bib45","series-title":"Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2019"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106119_bib46","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1530-0277.2008.00753.x","article-title":"Intermittent access to 20% ethanol induces high ethanol consumption in long\u2013evans and Wistar rats","volume":"32","author":"Simms","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106119_bib47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.alcohol.2014.03.002","article-title":"The alcohol deprivation effect model for studying relapse behavior: a comparison between rats and mice","volume":"48","author":"Vengeliene","year":"2014","journal-title":"Alcohol"},{"key":"10.1016\/j.ebiom.2025.106119_bib48","first-page":"9.49.1","article-title":"\u201cDrinking in the Dark\u201d (DID): a simple mouse model of binge-like alcohol intake","volume":"68","author":"Thiele","year":"2014","journal-title":"Curr Protoc Neurosci"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106119_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2313185121","article-title":"A macrophage-collagen fragment axis mediates subcutaneous adipose tissue remodeling in mice","volume":"121","author":"Vuji\u010di\u0107","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.106119_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106119_bib51","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/dom.14399","article-title":"Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis of randomised controlled trials","volume":"23","author":"Bray","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"13","key":"10.1016\/j.ebiom.2025.106119_bib52","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1038\/npp.2016.118","article-title":"Temporal rewiring of striatal circuits initiated by nicotine","volume":"41","author":"Adermark","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"D1","key":"10.1016\/j.ebiom.2025.106119_bib53","doi-asserted-by":"crossref","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: the Universal Protein Knowledgebase in 2025","volume":"53","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106119_bib54","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.amepre.2017.02.014","article-title":"Drinking beyond the binge threshold: predictors, consequences, and changes in the U.S","volume":"52","author":"Hingson","year":"2017","journal-title":"Am J Prev Med"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106119_bib55","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jamapsychiatry.2022.1240","article-title":"Association of drug cues and craving with drug use and relapse: a systematic review and meta-analysis","volume":"79","author":"Vafaie","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"20","key":"10.1016\/j.ebiom.2025.106119_bib56","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1007\/s00213-015-4027-6","article-title":"Cue reactivity and its relation to craving and relapse in alcohol dependence: a combined laboratory and field study","volume":"232","author":"Witteman","year":"2015","journal-title":"Psychopharmacology"},{"issue":"13","key":"10.1016\/j.ebiom.2025.106119_bib57","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106119_bib58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.ebiom.2025.106119_bib59","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in Metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106119_bib60","article-title":"The expanding benefits of GLP-1 medicines","volume":"6","author":"Gonzalez-Rellan","year":"2025","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106119_bib61","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106119_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106119_bib63","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/npp.2015.47","article-title":"Septal Glucagon-like peptide 1 receptor expression determines suppression of cocaine-induced behavior","volume":"40","author":"Harasta","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106119_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069010","article-title":"The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice","volume":"8","author":"Egecioglu","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106119_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077284","article-title":"The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice","volume":"8","author":"Egecioglu","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106119_bib66","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1038\/s41380-020-00957-3","article-title":"GLP-1 receptor signaling in the laterodorsal tegmental nucleus attenuates cocaine seeking by activating GABAergic circuits that project to the VTA","volume":"26","author":"Hernandez","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106119_bib67","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr5051","article-title":"An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking","volume":"11","author":"Merkel","year":"2025","journal-title":"Sci Adv"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106119_bib68","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00213-023-06376-w","article-title":"Liraglutide attenuates nicotine self-administration as well as nicotine seeking and hyperphagia during withdrawal in male and female rats","volume":"240","author":"Herman","year":"2023","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106119_bib69","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41386-019-0531-4","article-title":"Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats","volume":"45","author":"Zhang","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106119_bib70","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/adb.12295","article-title":"The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents","volume":"21","author":"Vall\u00f6f","year":"2016","journal-title":"Addict Biol"},{"key":"10.1016\/j.ebiom.2025.106119_bib71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pbb.2017.07.014","article-title":"The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice","volume":"160","author":"Thomsen","year":"2017","journal-title":"Pharmacol Biochem Behav"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106119_bib72","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1111\/acer.13199","article-title":"Effects of the GLP-1 agonist Exendin-4 on intravenous ethanol self-administration in mice","volume":"40","author":"S\u00f8rensen","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ebiom.2025.106119_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.599646","article-title":"Long-acting glucagon-like Peptide-1 receptor agonists suppress voluntary alcohol intake in Male Wistar rats","volume":"14","author":"Marty","year":"2020","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106119_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48267-2","article-title":"Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity","volume":"13","author":"Quddos","year":"2023","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106119_bib75","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106119_bib76","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1038\/s41591-025-03774-9","article-title":"Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial","volume":"31","author":"Martin","year":"2025","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106119_bib77","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41398-020-00923-1","article-title":"Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats","volume":"10","author":"Vall\u00f6f","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106119_bib78","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00213-023-06367-x","article-title":"Sex-dependent divergence in the effects of GLP-1 agonist exendin-4 on alcohol reinforcement and reinstatement in C57BL\/6J mice","volume":"240","author":"D\u00edaz-Megido","year":"2023","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106119_bib79","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae165","article-title":"GLP-1 and its analogs: does sex matter?","volume":"166","author":"B\u00f6rchers","year":"2025","journal-title":"Endocrinology"},{"key":"10.1016\/j.ebiom.2025.106119_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1265080","article-title":"Sex-divergent effects of hindbrain GLP-1-producing neuron activation in rats","volume":"17","author":"Lopez-Ferreras","year":"2023","journal-title":"Front Neurosci"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106119_bib81","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/mp.2017.187","article-title":"Lateral hypothalamic GLP-1 receptors are critical for the control of food reinforcement, ingestive behavior and body weight","volume":"23","author":"L\u00f3pez-Ferreras","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106119_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/s13293-016-0059-9","article-title":"Sex and estrogens alter the action of glucagon-like peptide-1 on reward","volume":"7","author":"Richard","year":"2016","journal-title":"Biol Sex Differ"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106119_bib83","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1172\/JCI1198","article-title":"Gender differences in ethanol preference and ingestion in rats. The role of the gonadal steroid environment","volume":"101","author":"Almeida","year":"1998","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106119_bib84","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0741-8329(92)90041-8","article-title":"Sex differences in pattern of drinking","volume":"9","author":"Lancaster","year":"1992","journal-title":"Alcohol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106119_bib85","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1038\/s41380-022-01599-3","article-title":"Top-down regulation of motivated behaviors via lateral septum sub-circuits","volume":"27","author":"Besnard","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ebiom.2025.106119_bib86","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.neubiorev.2021.03.029","article-title":"Lateral septum as a nexus for mood, motivation, and movement","volume":"126","author":"Wirtshafter","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106119_bib87","doi-asserted-by":"crossref","first-page":"E472","DOI":"10.1152\/ajpendo.00250.2023","article-title":"Brain access of incretins and incretin receptor agonists to their central targets relevant for appetite suppression and weight loss","volume":"326","author":"Buller","year":"2024","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106119_bib88","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/adb.12297","article-title":"Involvement of lateral septum in alcohol's dopamine-elevating effect in the rat","volume":"22","author":"Jonsson","year":"2017","journal-title":"Addict Biol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106119_bib89","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","article-title":"Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain","volume":"4","author":"Cork","year":"2015","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106119_bib90","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J Comp Neurol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106119_bib91","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/jnr.21349","article-title":"Immunohistochemical distribution of glucose-dependent insulinotropic polypeptide in the adult rat brain","volume":"85","author":"Nyberg","year":"2007","journal-title":"J Neurosci Res"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106119_bib92","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0196-9781(94)90016-7","article-title":"Gastric inhibitory polypeptide (GIP) binding sites in rat brain","volume":"15","author":"Kaplan","year":"1994","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106119_bib93","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2025.106119_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109637","article-title":"Uncovering CNS access of lipidated exendin-4 analogues by quantitative whole-brain 3D light sheet imaging","volume":"238","author":"Skovbjerg","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ebiom.2025.106119_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.86","article-title":"Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels","volume":"6","author":"Reddy","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.ebiom.2025.106119_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/adar.2023.10871","article-title":"Advances in DNA, histone, and RNA methylation mechanisms in the pathophysiology of alcohol use disorder","volume":"3","author":"Cruise","year":"2023","journal-title":"Adv Drug Alcohol Res"},{"key":"10.1016\/j.ebiom.2025.106119_bib97","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuropharm.2017.02.002","article-title":"Epigenetic basis of the dark side of alcohol addiction","volume":"122","author":"Pandey","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106119_bib98","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41591-024-03355-2","article-title":"Proteomic changes upon treatment with semaglutide in individuals with obesity","volume":"31","author":"Maretty","year":"2025","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106119_bib99","first-page":"4","article-title":"Sex differences in the neurobiology of alcohol use disorder","volume":"40","author":"Flores-Bonilla","year":"2020","journal-title":"Alcohol Res"},{"key":"10.1016\/j.ebiom.2025.106119_bib100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.alcohol.2025.01.003","article-title":"Sex and gender differences in alcohol use disorder: Quo Vadis?","volume":"123","author":"Witkiewitz","year":"2025","journal-title":"Alcohol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:45:01Z","timestamp":1775097901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425005699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":100,"alternative-id":["S2352396425005699"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106119","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tirzepatide reduces alcohol drinking and relapse-like behaviours in rodents","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106119"}}